Gerard Criner MD

Critical Care Medicine, Pleural Disease

Professor of Medicine, Temple Univ

3401 N Broad StPhiladelphia, PA 19140
Phone+1 215-707-5864
Fax+1 215-707-6867

Dr. Criner is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Criner's full profile Already have an account?

Education & Training

Boston University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1983 - 1986
Temple University HospitalResidency, Internal Medicine, 1979 - 1982
Lewis Katz School of Medicine at Temple UniversityClass of 1979

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

PA State Medical License 1980 - 2026
MD State Medical License 1986 - 1988
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

Philadelphia Magazine Castle Connolly, 2009-2014
America's Top Doctors Castle Connolly, 2009-2014
Super Doctor SuperDoctors.com

Clinical Trials

Benefits of Lightweight Ambulatory Oxygen Systems for Individuals With Chronic Obstructive Pulmonary Disease
TERMINATED
NA
Macrolide Azithromycin to Prevent Rapid Worsening of Symptoms Associated With Chronic Obstructive Pulmonary Disease
COMPLETED
NA
US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study
COMPLETED
PHASE2

Publications & Presentations

PubMed

Metabolomic profiling reveals distinct and shared biology in COPD and IPF.
Aldric Rosario, Nicole Prince, Shariq Madha-Krause, Sharon M Lutz, Julian E Hecker
Metabolomics. 2026-08-22
Associations Between Glucagon-like Peptide-1 Receptor Agonists and Respiratory Outcomes in Chronic Obstructive pulmonary disease and Diabetes.
Kuang-Ming Liao, Ya-Wen Tsai, Konstantinos Kostikas, Gerard J Criner, Jheng-Yan Wu
QJM. 2026-08-17
Using Historical Blood Eosinophil Counts to Guide Treatment Decisions in Patients With COPD.
Mona Bafadhel, Fernando J Martinez, Gerard J Criner, Donald P Tashkin, Michael E Wechsler
Chest. 2026-07-25

Journal Articles

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Gerard J Criner, Lavannya Pandit, The New England Journal of Medicine
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19
Robert L Gottlieb, Gerard J Criner, Onyema Ogbuagu, Kathleen M Mullane, Anuj Gaggar, Diana M Brainard, Gregory Huhn, JAMA
Association of Dysanapsis with Chronic Obstructive Pulmonary Disease Among Older Adults
Alain Bertoni, Gerard Criner, Mark T Dransfield, Meilan K Han, Nadia N Hansel, Erin D Michos, Elizabeth C Oelsner, Karol E Watson, JAMA

Authored Content

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020

Press Mentions

COPD Affects More Than Smokers — and Philadelphia’s Air Quality Makes Awareness CriticalNovember 3rd, 2025
As Pennsylvania Health Systems Rapidly Adopt AI, Lawmakers Take Steps to Regulate the TechnologyOctober 29th, 2025
The Multidisciplinary Future of Lung TransplantationSeptember 24th, 2025